HomeCompareIDRA vs DIVO

IDRA vs DIVO: Dividend Comparison 2026

IDRA yields 470.59% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IDRA wins by $38545.09M in total portfolio value
10 years
IDRA
IDRA
● Live price
470.59%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38545.12M
Annual income
$27,182,357,871.92
Full IDRA calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — IDRA vs DIVO

📍 IDRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIDRADIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IDRA + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IDRA pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IDRA
Annual income on $10K today (after 15% tax)
$40,000.00/yr
After 10yr DRIP, annual income (after tax)
$23,105,004,191.13/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, IDRA beats the other by $23,105,003,356.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IDRA + DIVO for your $10,000?

IDRA: 50%DIVO: 50%
100% DIVO50/50100% IDRA
Portfolio after 10yr
$19272.57M
Annual income
$13,591,179,426.80/yr
Blended yield
70.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on IDRA right now

IDRA
Analyst Ratings
5
Buy
4
Hold
Consensus: Buy
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IDRA buys
0
DIVO buys
0
No recent congressional trades found for IDRA or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIDRADIVO
Forward yield470.59%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$38545.12M$30.7K
Annual income after 10y$27,182,357,871.92$981.68
Total dividends collected$37542.88M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: IDRA vs DIVO ($10,000, DRIP)

YearIDRA PortfolioIDRA Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$57,759$47,058.82$11,349$649.42+$46.4KIDRA
2$315,826$254,024.51$12,833$688.83+$303.0KIDRA
3$1,636,076$1,298,141.44$14,459$727.90+$1.62MIDRA
4$8,035,425$6,284,824.27$16,238$766.49+$8.02MIDRA
5$37,445,846$28,847,941.19$18,179$804.47+$37.43MIDRA
6$165,706,448$125,639,392.36$20,293$841.71+$165.69MIDRA
7$696,916,266$519,610,366.98$22,591$878.14+$696.89MIDRA
8$2,788,074,169$2,042,373,764.24$25,087$913.65+$2788.05MIDRA
9$10,619,401,952$7,636,162,591.12$27,791$948.18+$10619.37MIDRA
10$38,545,117,961$27,182,357,871.92$30,718$981.68+$38545.09MIDRA

IDRA vs DIVO: Complete Analysis 2026

IDRAStock

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Full IDRA Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this IDRA vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IDRA vs SCHDIDRA vs JEPIIDRA vs OIDRA vs KOIDRA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.